Who invested in Resolve Therapeutics?
Resolve Therapeutics's investors include New Science Venture, Easton Capital and Washington Research Foundation.
United States · Series B startup
3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.9Mraised across 3 rounds since 2011, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $5.8M sold, first sale Nov 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Apr 2012
Reported by xconomy.comSEC filing: $2.0M sold, first sale May 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Resolve Therapeutics's investors include New Science Venture, Easton Capital and Washington Research Foundation.
Resolve Therapeutics has raised $8.9M across 3 rounds since 2011.
Resolve Therapeutics's most recent round was a Series B of $5.8M in Nov 2012.
Its most recent round, $5.8M in Nov 2012, is also its largest on record.
Resolve Therapeutics's first round on record, in May 2011, was backed by New Science Venture and Easton Capital.
Resolve Therapeutics's latest named round is a Series B, in Nov 2012.
Resolve Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.